N	Concordance
1	ients then receive 3 cycles of adjuvant methotrexate/vinblastine/cisplatin che
2	se following exposure to the antifolate methotrexate (MTX), suggesting that MTX 
3	articularly the antimetabolites such as methotrexate or fluorouracil, cause only
4	HFR-ricin cytotoxicity was inhibited by methotrexate, a DHFR inhibitor stabilizi
5	courses of  antimetabolite chemotherapy (methotrexate/fluorouracil) followed by 
6	rgh, found that CMF (cyclophosphamide,  methotrexate, fluorouracil) produced few
7	 d the combination of intermediate-dose methotrexate, bleomycin, doxorubicin, c
8	 (four 1.0 mg/kg doses of intramuscular methotrexate alternated with 0.1 mg/kg o
9	diation in combination with intrathecal methotrexate. Cranial irradiation does p
10	 e on days 1 through 14 and intravenous methotrexate and fluorouracil on days 1 
11	 vs. neoadjuvant chemotherapy with MVAC (methotrexate/vinblastine/doxorubicin/ci
12	 and in vivo percutaneous absorption of methotrexate and edatrexate through hair
13	patient was treated with two courses of methotrexate, which did not affect her h
14	 disease, low-dose IFN or low-dose oral methotrexate may be added. The three cla
15	rial. Of 51 patients allocated systemic methotrexate, 42 (82%) were successfully
16	ement  In vitro transport resistance to methotrexate demonstrated by bone marrow